| Hazard Information | Back Directory | [Description]
Bim 21009 is a gonadorelin inhibitor. | [Uses]
BIM 21009 is a LHRH and GnRH receptor antagonist. BIM 21009 inhibits tumor growth[1]. | [References]
[1] Ban E, Crumeyrolle-Arias M, Latouche J, Leblanc P, Heurtier JF, Drieu K, Fillion G, Haour F. GnRH receptors in rat brain, pituitary and testis; modulation following surgical and gonadotropin-releasing hormone agonist-induced castration. Mol Cell Endocrinol. 1990 Mar 26;70(1):99-107. DOI:10.1016/0303-7207(90)90063-e
[2] Bogden AE,et al. Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration. Cancer Res. 1990 May 1;50(9):2646-50. PMID:1970275 |
|
|